Literature DB >> 9459145

Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis.

K G Peters1, A Coogan, D Berry, J Marks, J D Iglehart, C D Kontos, P Rao, S Sankar, E Trogan.   

Abstract

Endothelial receptor tyrosine kinases may play important roles in pathological vascular growth, particularly in tumours. In this study, immunohistochemistry was used to evaluate the expression of a novel endothelial receptor tyrosine kinase, Tie2/Tek, in the endothelium of vascular 'hotspots' in normal breast tissue (n = 10), benign breast lesions (n = 10) and in breast tumours (n = 123). Tie2 expression was detected in the endothelium of all breast tissues examined. However, the strongest expression of Tie-2 was seen in vascular 'hot spots' within the inflammatory infiltrate at the periphery of invasive tumours. Moreover, the proportion of Tie2-positive vessels (Tie2 counts/CD31 counts) was significantly higher in breast tumours than the proportion of Tie2-positive vessels in either normal breast tissue or benign breast lesions (P = 0.004 and 0.0001 respectively). These data are consistent with a role for Tie2 in tumour angiogenesis and demonstrate the potential use of Tie2 expression as a novel marker of the tumour vasculature.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459145      PMCID: PMC2151265          DOI: 10.1038/bjc.1998.8

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  42 in total

1.  Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization.

Authors:  J Korhonen; J Partanen; E Armstrong; A Vaahtokari; K Elenius; M Jalkanen; K Alitalo
Journal:  Blood       Date:  1992-11-15       Impact factor: 22.113

2.  A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains.

Authors:  J Partanen; E Armstrong; T P Mäkelä; J Korhonen; M Sandberg; R Renkonen; S Knuutila; K Huebner; K Alitalo
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

3.  Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.

Authors:  G Gasparini; N Weidner; P Bevilacqua; S Maluta; P Dalla Palma; O Caffo; M Barbareschi; P Boracchi; E Marubini; F Pozza
Journal:  J Clin Oncol       Date:  1994-03       Impact factor: 44.544

4.  Microvessel quantitation and prognosis in invasive breast carcinoma.

Authors:  S Bosari; A K Lee; R A DeLellis; B D Wiley; G J Heatley; M L Silverman
Journal:  Hum Pathol       Date:  1992-07       Impact factor: 3.466

5.  Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas.

Authors:  A Kaipainen; T Vlaykova; E Hatva; T Böhling; A Jekunen; S Pyrhönen; K Alitalo
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

Review 6.  Angiogenesis and breast cancer.

Authors:  D F Hayes
Journal:  Hematol Oncol Clin North Am       Date:  1994-02       Impact factor: 3.722

7.  Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo.

Authors:  D J Dumont; G Gradwohl; G H Fong; M C Puri; M Gertsenstein; A Auerbach; M L Breitman
Journal:  Genes Dev       Date:  1994-08-15       Impact factor: 11.361

Review 8.  Clinical prognostic significance of tumour angiogenesis.

Authors:  P S Craft; A L Harris
Journal:  Ann Oncol       Date:  1994-04       Impact factor: 32.976

9.  Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms.

Authors:  K H Plate; G Breier; H A Weich; H D Mennel; W Risau
Journal:  Int J Cancer       Date:  1994-11-15       Impact factor: 7.396

10.  Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.

Authors:  H F Dvorak; T M Sioussat; L F Brown; B Berse; J A Nagy; A Sotrel; E J Manseau; L Van de Water; D R Senger
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  29 in total

Review 1.  Mathematical modeling of tumor-induced angiogenesis.

Authors:  Nikos V Mantzaris; Steve Webb; Hans G Othmer
Journal:  J Math Biol       Date:  2004-02-06       Impact factor: 2.259

2.  Use of adenoviral vectors to target chemotherapy to tumor vascular endothelial cells suppresses growth of breast cancer and melanoma.

Authors:  Pingchuan Li; Yanzheng Liu; Jonathan Maynard; Yucheng Tang; Albert Deisseroth
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

3.  Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis.

Authors:  Xuling Huang; Courtney Brown; Weihua Ni; Elizabeth Maynard; Alan C Rigby; Peter Oettgen
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

Review 4.  Is angiopoietin-2 necessary for the initiation of tumor angiogenesis?

Authors:  J Laurén; Y Gunji; K Alitalo
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 5.  Genes that regulate metastasis and angiogenesis.

Authors:  C P Webb; G F Vande Woude
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

6.  Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer.

Authors:  Yongfen Min; Xiubao Ren; David B Vaught; Jin Chen; Edwin Donnelly; Conor C Lynch; P Charles Lin
Journal:  Cancer Res       Date:  2010-03-16       Impact factor: 12.701

7.  Expression and significance of Tie-1 and Tie-2 receptors, and angiopoietins-1, 2 and 4 in colorectal adenocarcinoma: Immunohistochemical analysis and correlation with clinicopathological factors.

Authors:  Toshiyuki Nakayama; Go Hatachi; Chun-Yang Wen; Ayumi Yoshizaki; Kazuyuki Yamazumi; Daisuke Niino; Ichiro Sekine
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

8.  Expression of angiopoietin-2 gene and its receptor Tie2 in hepatocellular carcinoma.

Authors:  L Chen; Z Yang; G Wang; C Wang
Journal:  J Tongji Med Univ       Date:  2001

9.  Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2.

Authors:  Rebekah R White; Siqing Shan; Christopher P Rusconi; Geetha Shetty; Mark W Dewhirst; Christopher D Kontos; Bruce A Sullenger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-11       Impact factor: 11.205

10.  Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention.

Authors:  Mark Slevin; Jerzy Krupinski; Lina Badimon
Journal:  J Angiogenes Res       Date:  2009-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.